Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

73 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Exploring cytokine outputs for ex vivo diagnostics in drug reaction with eosinophilia and systemic symptoms (DRESS).
Copaescu AM, Mouhtouris E, James F, Goh MSY, Phillips EJ, Trubiano JA; for Australasian Registry of Severe Cutaneous Adverse Reactions (AUS-SCAR). Copaescu AM, et al. Among authors: goh msy. World Allergy Organ J. 2024 Dec 7;17(12):101002. doi: 10.1016/j.waojou.2024.101002. eCollection 2024 Dec. World Allergy Organ J. 2024. PMID: 39717677 Free PMC article.
Assessment of image quality on the diagnostic performance of clinicians and deep learning models: Cross-sectional comparative reader study.
Oloruntoba AI, Asghari-Jafarabadi M, Sashindranath M, Ingvar Å, Adler NR, Vico-Alonso C, Niklasson L, Caixinha AL, Hiscutt E, Holmes Z, Assersen KB, Adamson S, Jegathees T, Bertelsen T, Velasco-Tamariz V, Helkkula T, Kristiansen S, Toholka R, Goh MS, Chamberlain A, McCormack C, Vestergaard T, Mehta D, Nguyen TD, Ge Z, Soyer HP, Mar V. Oloruntoba AI, et al. Among authors: goh ms. J Eur Acad Dermatol Venereol. 2024 Dec 10. doi: 10.1111/jdv.20462. Online ahead of print. J Eur Acad Dermatol Venereol. 2024. PMID: 39655640
The Australasian Registry for Severe Cutaneous Adverse Reactions (AUS-SCAR) - Providing a roadmap for closing the diagnostic, patient, and healthcare gaps for a group of rare drug eruptions.
James F, Goh MS, Vogrin S, Ng I, Douglas AP, Holmes NE, Chua KY, De Luca J, Sharma P, Zubrinich C, Aung AK, Gin D, Lambros B, Baker C, Foley P, Chong AH, Thien F, Fok JS, Su J, Scardamaglia L, Awad A, Tong S, Johnson D, Godsell J, Arasu A, Barnes S, Ojaimi S, Mar A, Yun J, Ange N, Tong WWY, Carr A, Loprete J, Katelaris CH, Slape D, Keat K, West TA, Lee M, Smith W, Hissaria P, Sidhu S, Janson S, Venkatesan S, Davies J, Lane MJ, Redmond AM, Robertson I, Legg A, Fernando S, Boyle T, Li J, Phillips EJ, Cleland H, Kern JS, Trubiano JA. James F, et al. Among authors: goh ms. World Allergy Organ J. 2024 Aug 5;17(8):100936. doi: 10.1016/j.waojou.2024.100936. eCollection 2024 Aug. World Allergy Organ J. 2024. PMID: 39211425 Free PMC article.
Tildrakizumab use for recalcitrant pityriasis rubra pilaris.
Holmes Z, Goh MS, Foley P, Daniel BS. Holmes Z, et al. Among authors: goh ms. Australas J Dermatol. 2024 Aug;65(5):476-479. doi: 10.1111/ajd.14307. Epub 2024 May 30. Australas J Dermatol. 2024. PMID: 38814107 No abstract available.
Durability of immune responses after drug reaction with eosinophilia and systemic symptoms.
Awad A, Mouhtouris E, Clatch A, James F, Chua KYL, Holmes NE, Gibney G, Rose M, Copaescu A, Goh MS, Mackay LK, Christo SN, Gordon C, Philips EJ, Trubiano JA. Awad A, et al. Among authors: goh ms. J Allergy Clin Immunol Pract. 2024 Jan;12(1):232-235.e2. doi: 10.1016/j.jaip.2023.09.020. Epub 2023 Sep 29. J Allergy Clin Immunol Pract. 2024. PMID: 37778629 No abstract available.
73 results